Literature DB >> 2191070

Plasma fibrinogen--an independent cardiovascular risk factor.

E Ernst1.   

Abstract

Apart from being an acute phase reactant, fibrinogen appears to play an important although not widely recognized role in athero-/thrombogenesis. Arteriosclerotic diseases are associated with elevated levels of plasma fibrinogen. Strategies that lower the cardiovascular risk also lower fibrinogen levels. Virtually all accepted risk factors are associated with hyperfibrinogenaemia, while low risk populations usually have low fibrinogen levels. Epidemiological studies show that fibrinogen is a predictor of arteriosclerotic diseases. Its predictive power seems to be as high as or higher than accepted risk factors. These findings and other circumstantial, as well as experimental, evidence suggest that fibrinogen is a powerful, independent cardiovascular risk factor.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2191070     DOI: 10.1111/j.1365-2796.1990.tb00174.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  20 in total

Review 1.  Pathogenesis and pathology of coronary heart disease syndromes.

Authors:  P M Ridker; E M Antman
Journal:  J Thromb Thrombolysis       Date:  1999-10       Impact factor: 2.300

2.  Fibrinogen.

Authors:  E Ernst
Journal:  BMJ       Date:  1991-09-14

3.  Level of fibrinogen and risk of fatal and non-fatal stroke. EUROSTROKE: a collaborative study among research centres in Europe.

Authors:  M L Bots; P C Elwood; J T Salonen; A Freire de Concalves; J Sivenius; A Di Carlo; Y Nikitin; V Benetou; J Tuomilehto; P J Koudstaal; D E Grobbee
Journal:  J Epidemiol Community Health       Date:  2002-02       Impact factor: 3.710

4.  Plasma fibrinogen as cardiovascular risk factor.

Authors:  L Breimer
Journal:  Diabetologia       Date:  1995-05       Impact factor: 10.122

5.  Relations of cardiovascular risk factors to aortic pulse wave velocity in asymptomatic middle-aged women.

Authors:  A Taquet; C Bonithon-Kopp; A Simon; J Levenson; Y Scarabin; A Malmejac; P Ducimetiere; L Guize
Journal:  Eur J Epidemiol       Date:  1993-05       Impact factor: 8.082

6.  Population differences in proinflammatory biology: Japanese have healthier profiles than Americans.

Authors:  Christopher L Coe; Gayle D Love; Mayumi Karasawa; Norito Kawakami; Shinobu Kitayama; Hazel R Markus; Russell P Tracy; Carol D Ryff
Journal:  Brain Behav Immun       Date:  2010-11-26       Impact factor: 7.217

7.  A viscometric method of measuring plasma fibrinogen concentrations.

Authors:  E Ernst; K L Resch; T Saradeth; A Maier; A Matrai
Journal:  J Clin Pathol       Date:  1992-06       Impact factor: 3.411

Review 8.  Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms.

Authors:  I F Godsland; U Winkler; O Lidegaard; D Crook
Journal:  Drugs       Date:  2000-10       Impact factor: 9.546

9.  Protective effect of lupeol and lupeol linoleate in hypercholesterolemia associated renal damage.

Authors:  V Sudhahar; S Ashok Kumar; P Varalakshmi; V Sujatha
Journal:  Mol Cell Biochem       Date:  2008-06-19       Impact factor: 3.396

10.  Ethnic differences in risk markers for heart disease in Bradford and implications for preventive strategies.

Authors:  T Knight; Z Smith; J A Lockton; P Sahota; A Bedford; M Toop; E Kernohan; M R Baker
Journal:  J Epidemiol Community Health       Date:  1993-04       Impact factor: 3.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.